Abstract
Purpose
Macular pigment (MP) is believed to have a protective role in the development and progression of age-related maculopathy (ARM). We present results of measurements of macular pigment density (MPD) in patients with ARM at different stages with a modified confocal scanning laser ophthalmoscope (HRA, Heidelberg Engineering, Heidelberg, Germany).
Method
ARM patients were categorized into four groups. Staging depended upon the size of drusen, geographic atrophy, and loss of visual acuity due to ARMD in the fellow eye; 1: drusen size <125 μm, 2: drusen size >125 μm, 3: drusen size <125 μm+ARMD in fellow eye, and 4: drusen size >125 μm+ARMD in fellow eye. We took autofluorescence images at 488 nm and 514 nm with a modified HRA. MP density was evaluated within 2° around the center of the fovea. In this study, we included 146 patients with ARM: 26 in group 1, 19 in group 2, 80 in group 3, and 21 in group 4.
Results
The mean MPD of the different stages of ARM was: in group 1, 0.233±0.091 DU; group 2, 0.218±0.102 density units (DU); group 3, 0.252±0.085 DU; and group 4, 0.208±0.100 DU. Statistical analysis (Kruskal–Wallis test) showed no differences between groups.
Conclusions
Recent studies in ARM did not result in significant differences of MPD between the various stages of ARM. Further longitudinal studies are requested to compare the incidence of ARMD in eyes with high and low MPD in order to provide definite evidence of the influence of MPD on the progression of ARMD.
Similar content being viewed by others
References
Age-Related Eye Disease Study Research Group (2001) A randomized, placebo-controlled, clinical trial of high-dose: supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. Arch Ophthalmol 119:1417
Beatty S, Boulton M, Henson D, Koh HH, Murray IJ (1999) Macular pigment and age related macular degeneration. Br J Ophthalmol 83:867–877
Beatty S, Koh H-H, Henson DB, Boulton ME (2000) The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 45:115–134
Beatty S, Murray IJ, Henson DB, Carden D, Koh H-H, Boulton ME (2001) Macular pigment and risk for age-related macular degeneration in subjects from a northern European population. Invest Ophthalmol Vis Sci 42:439–446
Berendschot TT, Goldbohm RA, Klopping WA, van de Kraats J, van Norel J, van Norren D (2000) Influence of lutein supplementation on macular pigment, assessed with two objective techniques. Invest Ophthalmol Vis Sci 41:3322–3326
Berendschot TT, Willemse-Assink JJM, Bastiaanse M, de Joung PTVM, van Norren D (2002) Macular pigment and melanin in age-related maculopathy in a general population. Invest Ophthalmol Vis Sci 43:1928–1932
Bernstein PS, Yoshida MD, Katz NB, McClane RW, Gellermann W (1998) Raman detection of macular carotenoid pigments in intact human retina. Invest Ophthalmol Vis Sci 39:2003–2011
Bird AC, Bressler NM, Bressler SB, Chisholm IH, Coscas G, Davis MD, de Jong PTVM, Klaver CCW, Klein BEK, Klein R, Mitchell P, Sarks JP, Sarks SH, Soubrane G, Taylor HR, Vingerling JR (1995) An international classification and grading system for age-related maculopathy and age-related macular degeneration. Surv Ophthalmol 39:367–374
Bone RA, Landrum JT, Fernandez L, Tarsis SL (1988) Analysis of the macular pigment by HPLC: retinal distribut age study. Invest Ophthalmol Vis Sci 29:843–849
Bone RA, Landrum JT, Mayne ST, Gomez CM, Tibor SE, Twaroska EE (2001) Macular pigment in donor eyes with and without AMD: a case-control study. Invest Ophthalmol Vis Sci 42:235–240
Bressler NM, Bressler SB, Fine SL (1988) Age-related macular degeneration. Surv Ophthalmol 32:375–413
Cai J, Nelson DE, Wu M, Sternberg P, Jones DP (2000) Oxidative damage and protection of the RPE. Prog Retin Eye Res 19:205–221
Chaine G, Hullo A, Sahel J, Soubrane G, Espinasse-Berrod MA, Schutz D, Bourguignon C, Harpey C, Bourgeois H, Study-Group F-D (1998) Case-control study of the risk factors for age related macular degeneration. Br J Ophthalmol 82:996–1002
De La Paz MA, Anderson RE (1992) Lipid peroxidation in rod outer segments. Role of hydroxyl and lipid hydroperoxides. Invest Ophthalmol Vis Sci 33:2091–2096
Delcourt C, Cristol JP, Tessier F, Leger CL, Descomps B, Papoz L, POLA Study Group (1999) Age-related macular degeneration and antioxidant status in the POLA study. Arch Ophthalmol 117:1384–1390
Delori FC (1993) Macular pigment density measured by reflectometry and fluorometry. In: Noninvasive assessment of the Visual System. OSA Technical Digest 1993, pp. 240–243
Delori FC, Goger DG, Hammond BR, Snodderly DM, Burns SA (2001) Macular pigment density measured by autofluorescence spectrometry: comparison with reflectometry and heterochromatic flicker photometry. J Opt Soc Am 18:1212–1130
Evans JR (2001) Risk factors for age-related macular degeneration. Prog Retin Eye Res 20:227–253
Ham WTJ, Mueller HA, Sliney DH (1976) Retinal sensitivity to damage from short wavelength light. Nature 260:153–155
Hammond BR Jr, Caruso-Avery M (2000) Macular pigment optical density in a Southwestern sample. Invest Ophthalmol Vis Sci 41:1492–1497
Hammond BRJ, Fuld K (1992) Interocular differences in macular pigment density. Invest Ophthalmol Vis Sci 33:350–355
Hammond BRJ, Johnson EJ, Russell RM, Krinsky NI, Yeum K-J, Edwards B, Snodderly DM (1997) Dietary modification of human macular pigment density. Invest Ophthalmol Vis Sci 38:1795–1801
Khachik F, Bernstein PS, Garland DL (1997) Identification of lutein and zeaxanthin oxidation products in and monkey retinas. Invest Ophthalmol Vis Sci 38:1802–1811
Klein R, Klein BEK, Jensen SC (1997) The relation of cardiovascular disease and its risk factors to the 5-year incidence of age-related maculopathy. The beaver dam eye study. Ophthalmology 104:1804–1812
Landrum JT, Bone RA (2001) Lutein, zeaxanthin, and the macular pigment. Arch Biochem Biophys 385:28–40
Landrum JT, Bone RA, Joa H, Kilburn MD, Moore LL, Sprague KE (1997) A one year study of the macular pigment: the effect of 140 d lutein supplement. Exp Eye Res 65:57–62
Landrum JT, Bone RA, Kilburn MD (1997) The macular pigment: a possible role in protection from age macular degeneration. Adv Pharmacol 38:537–556
van Leeuwen R, Chakravarthy U, Vingerling JR, Brussee C, Hooghart AJ, Mulder PG, de Jong P (2003) Grading of age-related maculopathy for epidemiological studies: is digital imaging as good as 35-mm film? Ophthalmology 110:1540–1544
van Leeuwen R, Klaver CCW, Vingerling JR, Hofman A, de Jong P (2003) The risk and natural course of age-related maculopathy. Arch Ophthalmol 121:519–526
Mares-Perlman JA, Brady WE, Klein R, VandenLangenberg GM, Klein BE, Palta M (1995) Dietary fat and age-related maculopathy. Arch Ophthalmol 113:743–748
McCarty CA, Mukesh BN, Fu CL (2001) Risk factors for age-related maculopathy. Arch Ophthalmol 119:1455–1462
Pauleikhoff D, Barondes MJ, Minassian D, Chisholm IH, Bird AC (1990) Drusen as risk factors in age related macular disease. Am J Ophthalmol 109:38–43
Pauleikhoff D, Harper A, Marshall J, Bird AC (1990) Aging changes in Bruch’s membrane. A histochemical and morphologic study. Ophthalmology 97:171–178
Pauleikhoff D, van Kuijk FJ, Bird AC (2001) Makuläres Pigment und altersabhängige Makuladegeneration. Ophthalmologe 98:511–519
Robson AG, Moreland JD, Pauleikhoff D, Morrissey T, Holder GH, Fitzke FW, Bird AC, van Kuijk FJ (2003) Macular pigment density and distribution: comparison of fundus autofluorescence with minimum motion photometry. Vision Res 43:1765–1775
Seddon JM, Ajani UA, Sperduto RD, Hiller R, Blair N, Burton TC, Farber MD, Gragoudas ES, Haller J, Miller DT et al (1994) Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. J Am Med Assoc 272:1413–1420
Snodderly DM (1995) Evidence for protection against age-related macular degeneration by carotenoids and antioxidant vitamins. Am J Clin Nutr 62(Suppl 6):1448S–1461S
Snodderly DM, Auran JD, Delori FC (1984) The macular pigment. II Spatial distribution in primate retinas. Invest Ophthalmol Vis Sci 25:674–685
Snodderly DM, Brown PK, Delori FC, Auran JD (1984) The macular pigment. I. Absorbance spectra, localization and discrimination from other yellow pigments in primate retinas. Invest Ophthalmol Vis Sci 25:660–673
Snodderly DM, Handelman GJ, Adler AJ (1991) Distribution of individual macular pigment carotenoids in central retina of macaque and squirrel monkeys. Invest Ophthalmol Vis Sci 32:268–279
The Eye Disease Case Control Study Group (1992) Risk factors for neovascular age-related macular degeneration. Arch Ophthalmol 110:1701–1708
Wooten BR, Hammond BRJ, Land RI, Snodderly DM (1999) A practical method for measuring macular pigment optical. Invest Ophthalmol Vis Sci 40:2481–2489
Wüstemeyer H, Jahn C, Nestler A, Barth T, Wolf S (2002) A new instrument for the quantification of macular pigment density: first results in patients with AMD and healthy subjects. Graefes Arch Clin Exp Ophthalmol 240:666–671
Wüstemeyer H, Moessner A, Jahn C, Wolf S (2003) Macular pigment density in healthy subjects quantified with a modified confocal scanning laser ophthalmoscope. Graefes Arch Clin Exp Ophthalmol 241:647–651
Young RW (1987) Pathophysiology of age-related macular degeneration. Surv Ophthalmol 31:291–306
Acknowledgment
Grant support: DFG Wo478/11.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jahn, C., Wüstemeyer, H., Brinkmann, C. et al. Macular pigment density in age-related maculopathy. Graefe's Arch Clin Exp Ophthalmol 243, 222–227 (2005). https://doi.org/10.1007/s00417-004-0995-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-004-0995-7